Connect with us


Polio-Like Illness On The Rise




So far in 2018, at least 106 confirmed cases of acute flaccid myelitis (AFM) have occurred in the U.S.1 The mysterious disease, which is reminiscent of polio, primarily affects children and can cause permanent paralysis, continues to baffle the U.S. Centers for Disease Control and Prevention (CDC), which has been investigating the disease since 2014.

It was that year when AFM cases first spiked, reaching 120 cases from August to December. The condition then seemingly took a year off, with only 22 confirmed cases in 2015, followed by another spike in 2016 (149 cases). The next year another lull ensued (just 33 cases were confirmed in 2017) and, as has been the ongoing pattern, 2018 marked the next two-year spike, with cases continuing to rise.

While some clues have been revealed regarding AFM, like the fact that most people have an onset between August and October, and experience a fever or mild respiratory illness beforehand, the CDC remains largely in the dark as to what is causing AFM and why some people recover, and others do not.

Parents Criticize CDC for Lack of Answers About Acute Flaccid Myelitis

Perhaps as mysterious as the disease itself is why the CDC, the U.S. health protection agency, remains largely in the dark about AFM, which is quickly becoming a prominent health issue. Parents and scientists alike have criticized the CDC for their lack of effective response.2

According to the CDC’s Dr. Nancy Messonnier, who is heading up the CDC’s AFM investigation, “I understand why parents are frustrated. I’m frustrated. I want answers too.”3 In a press briefing held in October 2018, Messonnier confirmed the CDC’s investigation is lacking answers, stating:4

“Despite extensive laboratory testing, we have not determined what pathogen or immune response caused the arm or leg weakness and paralysis in most patients. We don’t know who may be at higher risk for developing AFM or the reasons why they may be at higher risk. We don’t fully understand the long-term consequences of AFM.”

The Minnesota Department of Health (MDH) is investigating six cases of AFM in the state, which occurred since September 2018. In a letter to the CDC, Sen. Amy Klobuchar, D-Minn., expressed her concern about the rise in AFM cases and requested an update on the CDC’s investigation and progress in determining the cause of the disease as well as issuing updated treatment guidelines for health care practitioners.

“While I appreciate your response to my previous letters and willingness to provide staff briefings, important questions remain regarding the CDC’s efforts to address the … cases of AFM … Accordingly, I respectfully request answers to the following additional questions,” she wrote, asking the following questions:5

“Is there an update as to whether the CDC has identified a common etiology for the confirmed cases of AFM?”

“Which states have reported cases of AFM, and what is the breakdown of cases for each state? Do you have any other information as to the geographic areas that have been more affected by AFM?

Which states mandate reporting of potential AFM cases to the CDC? Do these or other states only require AFM reporting if an illness is first identified as an outbreak by state and local health departments or other state authorities?”

“Concerns have been raised that AFM may be underreported. Does the CDC have a view as to whether incidences of AFM are currently being underreported? If so, what factors contribute to the potential incidence of underreporting?”

“Is the CDC working with scientific experts to consolidate the existing research on AFM from various universities and other research institutions in an effort to provide both the families of those affected by AFM and clinicians the most updated information?”

 “A child who became paralyzed from AFM recently underwent an innovative surgery that established connections between newly transferred nerves and the affected muscles, ultimately enabling the child to walk again.

Has the CDC studied the safety and efficacy of the procedure for potential use in treating other former AFM cases?

What diagnostics and other tools are the CDC and other agencies exploring to enable the earlier detection of AFM and potentially minimize the impact of the condition once it is discovered?”

“Does the CDC have an estimate of the overall financial burden of AFM to a family with a child who develops the condition and requires long-term health care services?”

As the questions reveal, it seems the CDC has not released even some of the most basic data relating to AFM, including an updated breakdown of cases in each state and more detailed geographic information. There is also concern that AFM cases may be underreported, but data is lacking from the CDC to confirm or deny this.

Also noteworthy, the CDC has stated that no one has died from AFM in 2018, but there was at least one death in 2017 of a child with AFM. Minnesota Sen. Tina Smith and Iowa Sens. Chuck Grassley and Joni Ernst have also contacted the CDC in attempts to get more information about AFM.

What Has the CDC Revealed About AFM in 2018?

In November 2018, the CDC released a report about the increase in AFM in the U.S. Of the 106 patients with AFM classified from January to November 2, 2018, they say 80 cases were confirmed to be AFM, six were deemed probable and 20 were classified as noncases.

“This represents a threefold increase in confirmed cases compared with the same period in 2017,” according to the CDC. As for what’s known:

  • The median patient age was 4 years
  • 59 percent were male
  • 86 percent were white
  • 99 percent had symptoms consistent with a viral illness in the four weeks preceding the onset (symptoms included fever, respiratory symptoms and gastrointestinal symptoms)

So far, most cases seem to mimic symptoms found in various viral illnesses, including polio virus, nonpolio enteroviruses, adenoviruses and West Nile virus. That being said, specimens (stool, blood and cerebrospinal fluid) tested from AFM patients have so far been negative for polio virus and no pathogens have been consistently detected in spinal fluid.

In the latest round of testing for enterovirus/rhinovirus (EV/RV) in AFM patients, 54 percent tested positive for EV or RV, but most were from upper respiratory or stool/rectal swab specimens. Only two cerebrospinal fluid specimens tested positive, one for EV-A71 and one for EV-D68.

When the illness first spiked in 2014, it was around the time of an outbreak of respiratory illness caused by enterovirus (EV) D68, another “polio-like virus” that was associated with paralysis. However, according to the CDC, “Among the people confirmed with AFM, CDC did not consistently detect EV-D68 in every patient.”

In the press briefing, Messonnier again confirmed that no one underlying cause, viral or otherwise, has been identified:

“So for individual cases, we have determined causes. For example, we have detected enterovirus in several of these individual cases. There’s sort of a long list of other agents that we have found in one or two. But if you are having the peaks of disease every late summer and early fall, you would think we are finding a single agent. That is what we are not finding.

For individual cases we are finding agents, but nothing that provides the unifying diagnosis that we expect to explain this disease. I guess, if you want to be specific, I can tell you that in several of the cases we found enterovirus and several cases we found … rhinovirus … But again this is a wide variety of causes. It doesn’t explain the whole peak of disease.”

Has CDC Looked Into Provocation Poliomyelitis?

You’re only going to find what you’re looking for, and if you’re not looking for the right clues you could miss something important.

Case in point, in 2015, Dr. Allan Cunningham, a retired pediatrician from New York, wrote an intriguing analysis to the BMJ referring to the “U.S. mystery of acute flaccid myeltitis,” which at the time was just over 100 cases in 34 states, alongside a spate of more than 1,100 cases of EV D68, the latter of which did not seem to be the overriding cause.

He brought up an important phenomenon known as provocation poliomyelitis, which describes the increased risk of neurological complications known to occur if a person with a polio virus infection receives an injury to a skeletal muscle, which could include an injection from a vaccine.

There are more than 100 nonpolio enteroviruses, most of which are mild but some of which can infect the central nervous system and cause serious illness, including paralysis.

Enteroviruses are the most prevalent viruses in the world,” according to the European Centre for Disease Prevention and Control, which means it’s likely that some children receiving vaccinations are probably infected with an enterovirus at the time of the injection, perhaps displaying no symptoms or only mild fever or flu-like symptoms (and many physicians see no problem with vaccinating a child who is mildly ill).

Is it possible that provocation poliomyelitis could occur in children vaccinated while infected with a nonpolio enterovirus? It’s a question that the CDC should be considering.

Cunningham noted, “AFM may result from a direct virus attack on the spinal cord, or by an immune attack triggered by a virus, or by something else. If a polio-like virus is circulating in the U.S., the possibility of its provocation by one or more vaccines has to be considered.”

Signs and Symptoms of AFM

With cases of AFM on the rise, and a cause still unknown, it’s important to be on the lookout for potential signs and symptoms of AFM, particularly in children, which include:

Difficulty moving the eyes

Drooping eyelids

Facial droop or weakness

Difficulty swallowing

Slurred speech

Sudden arm or leg weakness

Loss of muscle tone

Loss of reflexes

If you notice any of these symptoms, seek medical care immediately as AFM can be life-threatening. According to the CDC:

“The most severe symptom of AFM is respiratory failure that can happen when the muscles involved with breathing become weak. This can require urgent ventilator support (breathing machine). In very rare cases, it is possible that the process in the body that triggers AFM may also trigger other serious neurologic complications that could lead to death.”

AFM shares symptoms with other neurologic diseases, including Guillain-Barre syndrome, making diagnosis difficult. Magnetic resonance imaging (MRI) may be necessary, along with lab tests on cerebrospinal fluid, in order to make a definitive diagnosis.

There is currently no specific treatment, according to the CDC, which states only that “a doctor who specializes in treating brain and spinal cord illnesses (neurologist) may recommend certain interventions on a case-by-case basis.”

They’re equally unhelpful when it comes to recommending tools for prevention: “Since we don’t know the cause of most of these AFM cases or what triggers this condition, there is no specific action to take to prevent AFM.”

Unfortunately, unless the CDC begins to explore all of the potential causes of AFM, including provocation poliomyelitis or even vaccine-derived polio virus (VDPV), which causes acute flaccid paralysis, we may continue to remain in the dark for some time.


Source link

قالب وردپرس


Post-vaccine surge? Michigan’s spring coronavirus case spike close to previous year’s autumn high




(Natural News) The spike in new Wuhan coronavirus infections recorded in Michigan over the spring is similar to a spike seen during the 2020 fall season. According to a Wall Street Journal analysis, the state’s daily coronavirus case count averaged more than 7,000 for almost two weeks – before taking a slight dip to 6,891 on April 20. This echoed similar figures back in November and December 2020, which saw sharp rises in infections for those two months before plunging.

Back in autumn of last year, Michigan averaged more than 7,000 cases per day for a span of 10 days. New infections dropped slightly, then briefly spiked as the December holidays approached. It then fell to the low 1,000s for the succeeding two months – until ascending again in March.

According to University of Michigan internal medicine professor Dr. Vikas Parekh, the sudden increase in new infections could be attributed to several factors. Among the factors he cited was re-openings, which increased people’s interactions and mobility. Parekh said the loosened restrictions contributed to the spread of the highly contagious U.K. B117 variant.

“As the B117 variant spreads nationally, we will likely see other stats [with] their own surges – although I hope none are as bad as Michigan,” the professor remarked. He continued: “The milestone just tells us we are not yet in the clear, especially as we still have large portions of our population who are not vaccinated yet.”

Parekh also expressed optimism over the lower daily caseloads the Great Lakes State reported. He said he believes both cases and hospitalizations have plateaued and will likely decline soon. The professor commented: “[COVID-19] positivity has been declining now for one week, which is usually a leading indicator of case decline.”

Meanwhile, the state cited younger populations and youth sports, such as basketball, wrestling and hockey, to increase new COVID-19 infections. Because of this, Gov. Gretchen Whitmer called to suspend youth sports and indoor dining in the state. She also exhorted high schools to conduct remote class sessions for two weeks to curb the spread of the pathogen.

Michigan still experienced the spike in cases despite having one of the highest vaccination rates in the country

During the opening stages of the U.S.’s immunization drive against COVID-19, Michigan boasted of having one of the highest vaccination rates nationwide. A report by Bridge Michigan even noted the initial “frenzy for vaccines” that “far exceeded the state’s limited supply.” But things have appeared to turn around for Michigan, as it now struggles to reach the 70 percent vaccination rate needed for herd immunity.

Continue Reading


Scottish mom’s legs turn into a pair of “giant blisters” after first dose of AstraZeneca’s coronavirus vaccine




(Natural News) Sarah Beuckmann of Glasgow, Scotland, felt a tingling sensation in her legs and noticed a rash flaring up around her ankles a week after getting her first dose of AstraZeneca’s coronavirus (COVID-19) vaccine on March 18.

She also had flu-like symptoms right after the vaccination.

Beuckmann called her doctor to arrange an appointment the morning she noticed the rash, but by the afternoon her skin was already breaking out into blood-filled blisters. Blisters also appeared on her legs, hands, face, arms and bottom.

“I ended up asking my husband to take me to A&E,” said Beuckmann, referring to “accident and emergency,” the equivalent of an emergency room (ER). “When I got there, my heart rate was sitting at 160bpm, which they were very concerned about. I got put on an ECG machine.”

Doctors determine AstraZeneca’s COVID-19 vaccine triggers the rash

Medics carried out tests for HIV, herpes and other skin conditions to work out what triggered the rash, but all results came back negative. Doctors finally determined that the vaccine caused her rare reaction after carrying out two biopsies.

“Once they found that it was a reaction to the vaccine, they put me on steroids and that really seems to be helping my progress,” said Beuckmann. She had been advised by her doctor not to get the second dose of AstraZeneca’s COVID-19 vaccine because of her reaction.

Beuckmann spent 16 days at Queen Elizabeth University Hospital. She was discharged to recover at home. The 34-year-old mother of one is currently wheelchair-bound due to the bandages on her legs and blisters on the soles of her feet. She may need physiotherapy to help strengthen her leg muscles.

“They are starting to heal and they’re looking a lot better than they were but as the blisters started to get worse, they all sort of merged together,” she said. “I didn’t know what was going on.”

With the blisters merging, her legs have looked like a pair of “giant blisters.” Beuckmann admitted that at one point she feared her legs might have to be amputated.

Dermatologist agrees COVID-19 vaccine causes the blisters

Dr. Emma Wedgeworth, a consultant dermatologist and spokeswoman at the British Skin Foundation, agreed that Beuckmann had likely suffered a reaction to the vaccine.

“Vaccines are designed to activate the immune system. Occasionally people will have quite dramatic activation of their immune systems which, as happened in this case, can manifest in their skin” Wedgeworth told MailOnline. “This poor lady had a very severe reaction, which thankfully is extremely rare.”

It is not clear why Beuckmann, who works in retail, was invited for a vaccine. Scotland’s vaccine rollout was focused on people over the age of 50 when she got vaccinated, although vaccines are available to those who are considered at risk from the virus, or live with someone considered vulnerable.

At least 20 million Briton have had AstraZeneca’s COVID-19 vaccine, which drug regulators say causes a rash in one percent of cases. They say rashes caused by the jab tend to go away within a week.

Continue Reading


Trojan labs? Chinese biotech company offers to build COVID testing labs in six states




In 2012, BGI acquired Complete Genomics, a DNA sequencing company and equipment maker. The funds for the $117.6 million purchase were raised from Chinese venture capitals. The company has expanded its footprint globally. According to its website, BGI conducts business in more than 100 countries and areas and has 11 offices and labs in the U.S.

People are concerned about China’s access to American DNA data

Some said that with Complete Genomics providing an American base, BGI would have access to more DNA samples from Americans, helping it compile a huge database of genetic information. Some also worried about the protection of the genetic information’s privacy.

According to a 2019 report from the U.S.–China Economic and Security Review Commission (USCC), BGI “has formed numerous partnerships with U.S. healthcare providers and research organizations to provide large-scale genetic sequencing to support medical research efforts,”

There are three main reasons why many people in the biotech community and government have expressed concerns about China’s access to American DNA data.

In the “60 Minutes” interview, Evanina discussed the very likely scenario in which Chinese companies would be able to micro-target American individuals and offer customized preventative solutions based on their DNA.

Evanina asked: “Do we want to have another nation systematically eliminate our healthcare services? Are we okay with that as a nation?”

The second concern is that China may use DNA to track and attack American individuals. As the USCC report states: “China could target vulnerabilities in specific individuals brought to light by genomic data or health records. Individuals targeted in such attacks would likely be strategically identified persons, such as diplomats, politicians, high-ranking federal officials or military leadership.”

The third concern is that China may devise bioweapons to target non-Asians. Steven Mosher, president of the Population Research Institute, discussed it in his article “What Will China Do With Your DNA?” published by The Epoch Times in March 2019.

He wrote: “We know that the Asian genome is genetically distinct from the Caucasian and African in many ways. … Would it be possible to bioengineer a very virulent version of, say, smallpox, that was easily transmitted, fatal to other races, but to which the Chinese enjoyed a natural immunity? … Given our present ability to manipulate genomes, if such a bio-weapon can be imagined, it can probably – given enough time and resources – be realized.”

An article from Technocracy said: “China’s aggressive collection of American DNA should be doubly alarming because it can only spell one ultimate outcome: biowarfare. That is, genetically engineering viruses or other diseases that will be selectively harmful to U.S. populations.”

Continue Reading